Poland· PL-100037649
Lignocainum 2% c. noradrenalino 0,00125% WZF
A lidocain, kombinationen product containing lidocaini hydrochloridum monohydricum + noradrenalini tartras, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lidocain, kombinationen is registered in 11 of 19 countries.
Countries holding a registration under ATC N01BB52 (lidocain, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Lidocain, kombinationen · ATC N01BB52
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Lidocaini hydrochloridum monohydricum + Noradrenalini tartras
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- N01BB52
- ATC class
- Lidocain, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990092819
- gtin05909990092826
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N01BB52
Lidocain, kombinationen, as other registers publish it.
- IrelandAnbesol Anaesthetic Antiseptic Oromucosal SolutionAlliance Pharma (Ireland) Limited
- PolandAnesdermPierre Fabre Medicament
- BelgiumAnusol 10 mg - 280 mgKenvue Belgium
- PolandCalgelInPharm Sp. z o.o.
- PolandCalgelMcNeil Healthcare (Ireland) Limited
- NetherlandsCathejell 20 mg/0,5 mg gelMontavit GMBH
- BelgiumEmerxil SprayNovum Pharma
- PolandEmlaDelfarma Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0443319a-bc94-45a8-ab6b-7de90133899f GET /v1/drugs/0443319a-bc94-45a8-ab6b-7de90133899f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "(20 mg + 0,025 mg)/ml",
"packaging": "05909990092819 ¦ Rp ¦ 5799\n10 amp. 2 ml\n05909990092826 ¦ Rp ¦ Skasowane ¦ 5800\n50 amp. 2 ml",
"substance": "Lidocaini hydrochloridum 20 mg + Noradrenalini tartras 0.025 mg",
"common_name": "Lidocaini hydrochloridum monohydricum + Noradrenalini tartras",
"pl_product_id": "100037649",
"pozwolenie_nr": "00928",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about lidocain, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.